Drug Shortage Report for AURO-CANDESARTAN HCT
Report ID | 47473 |
Drug Identification Number | 02421038 |
Brand name | AURO-CANDESARTAN HCT |
Common or Proper name | CANDESARTAN HCT |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL |
Strength(s) | 12.5MG 16MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2018-03-30 |
Actual start date | |
Estimated end date | 2018-05-18 |
Actual end date | 2018-07-12 |
Shortage status | Resolved |
Updated date | 2018-07-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-07-13 | French | Compare |
v3 | 2018-07-13 | English | Compare |
v2 | 2018-04-30 | French | Compare |
v1 | 2018-04-30 | English | Compare |
Showing 1 to 4 of 4